|
Parameters
|
Group 1 (open drainage)
|
Group 2 (closed drainage)
|
p value
|
|---|
|
Number of patients
|
56
|
200
| |
|
Donor age (years)
|
46.5 (24–74)
|
49.0 (15–76)
|
0.7 (ns)
|
|
Donor gender (m:f)
|
29:27
|
96:104
|
0.4 (ns)
|
|
Donor CMV-positive
|
34 (61 %)
|
110 (55 %)
|
0.2 (ns)
|
|
Donor ICU stay (days)
|
6 (1–16)
|
5 (1–14)
|
0.7 (ns)
|
|
Donor steatosis hepatis
|
|
No
|
42 (75 %)
|
161 (80 %)
|
0.8 (ns)
|
|
Moderate
|
11 (20 %)
|
35 (17.5 %)
|
0.9 (ns)
|
|
Severe
|
3 (5 %)
|
4 (2 %)
|
0.8 (ns)
|
|
Recipient age (years)
|
51.4 (12–68)
|
52.6 (16–67)
|
0.3 (ns)
|
|
Recipient gender (m:f)
|
44:12
|
153:47
|
0.9 (ns)
|
|
Recipient CMV-positive
|
37 (66 %)
|
141 (70 %)
|
0.3 (ns)
|
|
CMV (donor+/recip.−)
|
12 (21 %)
|
38 (19 %)
|
0.8 (ns)
|
|
MELD score
|
17.0 (8–39)
|
16 (7–40)
|
0.3 (ns)
|
|
Body Mass Index
|
25.9 (17.4–35.4)
|
26.6 (18.5–36.2)
|
0.9 (ns)
|
|
Underlying disease
|
|
Hepatitis B
|
5 (9 %)
|
13 (7 %)
|
0.4 (ns)
|
|
Hepatitis C
|
13 (23 %)
|
47 (24 %)
|
0.6 (ns)
|
|
Cryptogenic
|
2 (4 %)
|
12 (6 %)
|
0.4 (ns)
|
|
Primary biliary cirrhosis
|
1 (2 %)
|
9 (4.5 %)
|
0.3 (ns)
|
|
Biliary atresia
|
0
|
1 (0.5 %)
|
0.8 (ns)
|
|
Sclerosing cholangitis
|
1 (2 %)
|
5 (2.5 %)
|
0.6 (ns)
|
|
Autoimmune hepatitis
|
1 (2 %)
|
4 (2 %)
|
0.7 (ns)
|
|
Metabolic
|
0
|
11 (5.5 %)
|
0.1 (ns)
|
|
Acute liver failure
|
4 (7 %)
|
14 (7 %)
|
0.6 (ns)
|
|
Chronic alcoholic
|
29 (52 %)
|
84 (42 %)
|
0.5 (ns)
|
|
Presence of HCCa
|
24 (43 %)
|
69 (34.5 %)
|
0.1 (ns)
|
|
Child-Pugh score
|
|
Child A
|
10 (18 %)
|
42 (21 %)
|
0.9 (ns)
|
|
Child B
|
32 (57 %)
|
110 (55 %)
|
0.9 (ns)
|
|
Child C
|
14 (25 %)
|
48 (24 %)
|
0.8 (ns)
|
|
Previous abdominal surgery
|
24 (43 %)
|
85 (42.5 %)
|
0.5 (ns)
|
|
Preoperative portal vein thrombosis
|
2 (4 %)
|
10 (5 %)
|
0.5 (ns)
|
|
Retransplantation
|
3 (5 %)
|
15 (7.5 %)
|
0.4 (ns)
|
- Values are expressed as median (range)
-
Group 1 open-circuit drainage (Easy Flow Drain), Group 2 closed-circuit drainage (Robinson Drainage System)
-
aHepatocellular carcinoma
